# Insulin Human (Genetical Recombination) Injection (ヒューマリン３／７注ミリオペン)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 2492413G9025). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 2492413G9025
- **Product name (Japanese):** ヒューマリン３／７注ミリオペン
- **English title:** Insulin Human (Genetical Recombination) Injection
- **Active ingredient:** インスリン ヒト（遺伝子組換え）
- **Active ingredient (INN):** Insulin Human (Genetical Recombination)
- **Strength / unit:** ３００単位１キット
- **Route:** Injection (注射薬)
- **Therapeutic category:** 24 Hormones (incl. antihormones) (ホルモン剤（抗ホルモン剤を含む）) › 249 Other hormones (その他のホルモン剤)
- **Manufacturer:** Eli Lilly Japan (日本イーライリリー)
- **NHI price (reference only):** JPY 1296 per ３００単位１キット
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/2492413G9025
- **JSON:** https://www.nifujipharma.com/api/drugs/2492413G9025

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Insulin%20Human%20(Genetical%20Recombination)%20Injection%20(%E3%83%92%E3%83%A5%E3%83%BC%E3%83%9E%E3%83%AA%E3%83%B3%EF%BC%93%EF%BC%8F%EF%BC%97%E6%B3%A8%E3%83%9F%E3%83%AA%E3%82%AA%E3%83%9A%E3%83%B3)%20%2F%20YJ%202492413G9025#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Insulin Human (Genetical Recombination)

- [Insulin Human (Genetical Recombination) Injection 100 Units/mL (ヒューマリンＮ注１００単位／ｍＬ)](https://www.nifujipharma.com/drugs/2492403A3047) — １００単位１ｍＬバイアル, Eli Lilly Japan
- [Insulin Human (Genetical Recombination) Injection 100 Units/mL (ノボリンＲ注 １００単位／ｍＬ)](https://www.nifujipharma.com/drugs/2492403A4043) — １００単位１ｍＬバイアル, Novo Nordisk Pharma
- [Insulin Human (Genetical Recombination) Injection 100 Units/mL (ヒューマリンＲ注１００単位／ｍＬ)](https://www.nifujipharma.com/drugs/2492403A4051) — １００単位１ｍＬバイアル, Eli Lilly Japan
- [Insulin Human (Genetical Recombination) Injection 100 Units/mL (ヒューマリン３／７注１００単位／ｍＬ)](https://www.nifujipharma.com/drugs/2492403H1034) — １００単位１ｍＬバイアル, Eli Lilly Japan
- [Insulin Human (Genetical Recombination) Injection (ヒューマリンＲ注カート)](https://www.nifujipharma.com/drugs/2492403H4041) — ３００単位１筒, Eli Lilly Japan
- [Insulin Human (Genetical Recombination) Injection (ヒューマリンＮ注カート)](https://www.nifujipharma.com/drugs/2492403H5030) — ３００単位１筒, Eli Lilly Japan
- [Insulin Human (Genetical Recombination) Injection (ヒューマリン３／７注カート)](https://www.nifujipharma.com/drugs/2492403H6036) — ３００単位１筒, Eli Lilly Japan
- [Insulin Human (Genetical Recombination) Injection (ノボリンＮ注フレックスペン)](https://www.nifujipharma.com/drugs/2492413G1059) — ３００単位１キット, Novo Nordisk Pharma
- [Insulin Human (Genetical Recombination) Injection (ノボリン３０Ｒ注フレックスペン)](https://www.nifujipharma.com/drugs/2492413G5054) — ３００単位１キット, Novo Nordisk Pharma
- [Insulin Human (Genetical Recombination) Injection (ノボリンＲ注フレックスペン)](https://www.nifujipharma.com/drugs/2492413G8053) — ３００単位１キット, Novo Nordisk Pharma
- [Insulin Human (Genetical Recombination) Injection (ヒューマリンＮ注ミリオペン)](https://www.nifujipharma.com/drugs/2492413P1024) — ３００単位１キット, Eli Lilly Japan
- [Insulin Human (Genetical Recombination) Injection (ヒューマリンＲ注ミリオペン)](https://www.nifujipharma.com/drugs/2492413P2020) — ３００単位１キット, Eli Lilly Japan